Bank Of Montreal Cardiol Therapeutics Inc. Transaction History
Bank Of Montreal
- $214 Billion
- Q3 2024
A detailed history of Bank Of Montreal transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 50,000 shares of CRDL stock, worth $67,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,112
0.22%
Holding current value
$67,500
Previous $101,000
1.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRDL
# of Institutions
47Shares Held
6.43MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X03.12MShares$4.21 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.58 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.07 Million0.31% of portfolio
-
Lion Street Advisors, LLC308KShares$415,3490.13% of portfolio
-
Atria Investments LLC Charlotte, NC136KShares$183,4520.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $83.6M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...